Foster & Motley Inc. Takes $1.50 Million Position in Cencora, Inc. $COR

Foster & Motley Inc. purchased a new position in Cencora, Inc. (NYSE:COR) during the second quarter, Holdings Channel.com reports. The institutional investor purchased 5,317 shares of the company’s stock, valued at approximately $1,505,000.

Several other large investors have also recently made changes to their positions in COR. Kemnay Advisory Services Inc. purchased a new position in Cencora in the 4th quarter valued at $25,000. Oakworth Capital Inc. purchased a new stake in shares of Cencora during the fourth quarter worth $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora during the fourth quarter worth $27,000. Elevation Wealth Partners LLC raised its position in shares of Cencora by 506.2% in the second quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock valued at $27,000 after buying an additional 81 shares during the last quarter. Finally, Archer Investment Corp raised its position in shares of Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after buying an additional 47 shares during the last quarter. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Royal Bank Of Canada initiated coverage on shares of Cencora in a research report on Wednesday. They set a “sector perform” rating and a $330.00 price target on the stock. Wall Street Zen upgraded shares of Cencora from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Weiss Ratings raised shares of Cencora from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 6th. Citigroup restated a “buy” rating on shares of Cencora in a report on Thursday, August 6th. Finally, Barclays dropped their price target on Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, June 10th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $370.85.

Cencora Stock Performance

Cencora stock opened at $316.78 on Thursday. The firm has a 50 day simple moving average of $301.20 and a 200-day simple moving average of $312.16. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The company has a debt-to-equity ratio of 3.53, a current ratio of 0.93 and a quick ratio of 0.58. The stock has a market cap of $60.45 billion, a price-to-earnings ratio of 23.53, a price-to-earnings-growth ratio of 1.81 and a beta of 0.57.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, beating the consensus estimate of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The firm had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. During the same quarter in the previous year, the company earned $4.00 EPS. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. On average, analysts expect that Cencora, Inc. will post 17.87 EPS for the current year.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s dividend payout ratio (DPR) is 17.83%.

Cencora announced that its board has authorized a stock buyback plan on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its shares are undervalued.

Insider Buying and Selling

In other Cencora news, Director Lauren M. Tyler bought 550 shares of Cencora stock in a transaction on Monday, June 22nd. The shares were bought at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the transaction, the director directly owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.38% of the stock is owned by corporate insiders.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.